Trial intelligence / Profile preview

Mucosal Visualization and Diagnostic Performance in Small Bowel Capsule Endoscopy Using Different Preparation Protocols

2025-520671-38-00Phase 4Authorised

Sponsor
Hospital Universitario La Paz
Start
Jan 2025
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised trial of macrogol and simethicone (2 arms), sponsored by Hospital Universitario La Paz. Primary endpoint: Degree of small bowel cleansing. Planned start Jan 2025; status: authorised.

02

Drugs

macrogolsimethicone

Beyond the preview

Go deeper on 2025-520671-38-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2025-520671-38-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call